Christian Pierret - ABIVAX Socit Director
| AAVXF Stock | USD 15.15 4.20 38.36% |
Director
Christian Pierret is Director of ABIVAX Socit Anonyme
| Phone | 33 1 53 83 08 41 |
| Web | https://www.abivax.com |
ABIVAX Socit Management Efficiency
The company has return on total asset (ROA) of (0.4368) % which means that it has lost $0.4368 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (12.8647) %, meaning that it generated substantial loss on money invested by shareholders. ABIVAX Socit's management efficiency ratios could be used to measure how well ABIVAX Socit manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Steven Pfeiffer | Barloworld Ltd ADR | 63 | |
| Nomavuso Mnxasana | Barloworld Ltd ADR | 60 | |
| Gavin Knight | Barloworld Ltd ADR | N/A | |
| Babalwa Ngonyama | Barloworld Ltd ADR | 40 | |
| Dominic Sewela | Barloworld Ltd ADR | 51 | |
| Alexander Landia | Barloworld Ltd ADR | 50 | |
| Sango Ntsaluba | Barloworld Ltd ADR | 56 | |
| Alexander Hamilton | Barloworld Ltd ADR | 68 | |
| Oupa Shongwe | Barloworld Ltd ADR | 54 | |
| Donald Wilson | Barloworld Ltd ADR | 59 | |
| Neo Dongwana | Barloworld Ltd ADR | 44 | |
| Michael LynchBell | Barloworld Ltd ADR | 64 | |
| Peter Schmid | Barloworld Ltd ADR | 53 | |
| Sibongile Mkhabela | Barloworld Ltd ADR | 60 | |
| Ngozichukwuka Edozien | Barloworld Ltd ADR | 48 | |
| Hester Hickey | Barloworld Ltd ADR | 62 | |
| Frances Edozien | Barloworld Ltd ADR | 51 | |
Management Performance
| Return On Equity | -12.86 | |||
| Return On Asset | -0.44 |
ABIVAX Socit Anonyme Leadership Team
Elected by the shareholders, the ABIVAX Socit's board of directors comprises two types of representatives: ABIVAX Socit inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ABIVAX. The board's role is to monitor ABIVAX Socit's management team and ensure that shareholders' interests are well served. ABIVAX Socit's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ABIVAX Socit's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Miguel Sieler, Director | ||
| Alain Chevallier, Advisor | ||
| Philippe MD, Founder Director | ||
| Christian Pierret, Director | ||
| Bernard Fanget, Vice President - Process Development and Manufacturing | ||
| Hartmut Ehrlich, CEO | ||
| Didier Scherrer, Vice President - Research & Development Small Molecules | ||
| Vincent Serra, Vice President - Research & Development Viral Vaccines | ||
| JeanJacques Bertrand, Director | ||
| Prof Ehrlich, Chief Officer | ||
| Paul Gineste, VP Operations | ||
| Jerome Gallot, Director | ||
| Claude Bertrand, Director | ||
| Alexandra Pearce, Vice President and Head of Regulatory Affairs | ||
| Joy Amundson, Director | ||
| Pierre MBA, Chief Devel | ||
| Didier Blondel, CFO, Board Secretary | ||
| Regina Jehle, VP Communications | ||
| Karl Birthistle, Vice President Chief Medical Officer and Vice President Clinical & Regulatory Affairs | ||
| Pierre Courteille, Vice President - Business Development, Chief Commercial Officer | ||
| JeanMarc Steens, Chief Medical Officer | ||
| Anne Pascard, HR Mang | ||
| Antoine Pau, Director | ||
| Raquel Lizarraga, Investor Mang | ||
| JeanPaul Prieels, Director | ||
| Philippe Pouletty, Chairman of the Board |
ABIVAX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is ABIVAX Socit a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -12.86 | |||
| Return On Asset | -0.44 | |||
| Operating Margin | 4.66 % | |||
| Current Valuation | 165.28 M | |||
| Shares Outstanding | 22.3 M | |||
| Shares Owned By Insiders | 4.67 % | |||
| Shares Owned By Institutions | 57.27 % | |||
| Price To Earning | (7.88) X | |||
| Price To Book | 27.57 X | |||
| Price To Sales | 20.65 X |
Pair Trading with ABIVAX Socit
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ABIVAX Socit position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABIVAX Socit will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to ABIVAX Socit could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ABIVAX Socit when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ABIVAX Socit - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ABIVAX Socit Anonyme to buy it.
The correlation of ABIVAX Socit is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ABIVAX Socit moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ABIVAX Socit Anonyme moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ABIVAX Socit can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABIVAX Socit Anonyme. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for ABIVAX Pink Sheet analysis
When running ABIVAX Socit's price analysis, check to measure ABIVAX Socit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIVAX Socit is operating at the current time. Most of ABIVAX Socit's value examination focuses on studying past and present price action to predict the probability of ABIVAX Socit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABIVAX Socit's price. Additionally, you may evaluate how the addition of ABIVAX Socit to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |